Measured Move Target At 110Pretty simple analysis here:
touch of the bottom Keltner channel
potential weekly anti forming bearish
daily and weekly price action seem to deserve a second leg with the big surprise bear moves.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.44 EUR
12.90 B EUR
40.52 B EUR
1.72 B
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
FIGI
BBG00KTDT9Q6
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABT long at 126.75 -- bad new is good news (for me)ABT got some bad news today when a Missouri judge ruled there would be a retrlal regarding a court case involving ABT's baby formula, and the stock, which was already down 3 days in a row, got thumped. While I don't dismiss long term risk from that news, I'm not in this for the long haul. I will l
$ABT : Reversal Pattern Just Dropped – Is $115 the NextAlright, let’s check out ABT on the daily chart. The stock enjoyed a steady climb since Jan 2025, riding a clear uptrend line, and now just nailed a technical reversal pattern, and it seems like it’s aiming for a target around $115 per share in the short term (1-3 months).
Abbott Hitting its Top. ABTRSX Divergence and crosses on volatility and stochastic indicators below. A strong change in flavor of candlesticks now, despite no cross of MIDAS. This one has been climbing for quite a bit, and now it might be time for a correction if just a temporary one.
Abbott Laboratories | ABT | Long at $110.00Abbott Laboratories NYSE:ABT has been making higher highs and lower lows over the last year, potentially signaling a reversal in its downward trend. Monkeypox and the return of cold/flu/COVID season may spark another run to close the price gap on the daily chart around $140. It is currently in a p
Abbott and Amazon: Two Bright Spots in a Sea of Red◉ Abbott Laboratories NYSE:ABT
● The stock previously faced strong resistance near the $134 level, leading to an extended consolidation phase.
● During this period, a Rounding Bottom pattern emerged, signalling a potential continuation of the upward trend.
● Following a recent breakout, the stoc
ABT Bullish Momentum – Move Toward $141.60 ExpectedNYSE:ABT is showing strong bullish momentum, trading within an ascending channel and steadily approaching the upper boundary. The recent price action highlights consistent buying pressure, suggesting a potential continuation toward the $141.60 level.
The stock has maintained its position above key
Abbott LabAbbott Lab : Anticipate upside move because of Cup and handle pattern is slowly appearing.
Abbott Laboratories : Check for long positionABT : Look for long position
If the current price crosses the 133 mark, then anticipate the price to move up to 142.
ABT Strong Bullish Momentum – Move Toward $127.00 ExpectedNYSE:ABT is exhibiting strong bullish momentum, supported by a significant breakout above prior consolidation levels. The alignment of moving averages and the strength of recent price action suggest further upside potential, with the next logical target at $127.00.
The price has surged above key m
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABT is featured.
Related stocks
Frequently Asked Questions
The current price of ABT is 112.98 EUR — it has decreased by −0.41% in the past 24 hours. Watch ABBOTT LABORATORIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange ABBOTT LABORATORIES stocks are traded under the ticker ABT.
ABT stock has fallen by −6.80% compared to the previous week, the month change is a −9.92% fall, over the last year ABBOTT LABORATORIES has showed a 9.84% increase.
We've gathered analysts' opinions on ABBOTT LABORATORIES future price: according to them, ABT price has a max estimate of 139.18 EUR and a min estimate of 103.06 EUR. Watch ABT chart and read a more detailed ABBOTT LABORATORIES stock forecast: see what analysts think of ABBOTT LABORATORIES and suggest that you do with its stocks.
ABT stock is 2.05% volatile and has beta coefficient of 0.31. Track ABBOTT LABORATORIES stock price on the chart and check out the list of the most volatile stocks — is ABBOTT LABORATORIES there?
Today ABBOTT LABORATORIES has the market capitalization of 195.49 B, it has decreased by −6.21% over the last week.
Yes, you can track ABBOTT LABORATORIES financials in yearly and quarterly reports right on TradingView.
ABBOTT LABORATORIES is going to release the next earnings report on Apr 16, 2025. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.29 EUR per share, whereas the estimation was 1.29 EUR resulting in a 0.32% surprise. The estimated earnings for the next quarter are 0.99 EUR per share. See more details about ABBOTT LABORATORIES earnings.
ABBOTT LABORATORIES revenue for the last quarter amounts to 10.60 B EUR, despite the estimated figure of 10.66 B EUR. In the next quarter, revenue is expected to reach 9.62 B EUR.
ABT net income for the last quarter is 8.88 B EUR, while the quarter before that showed 1.47 B EUR of net income which accounts for 503.02% change. Track more ABBOTT LABORATORIES financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.52 EUR. As of today, Dividend Yield (TTM)% is 1.75%. Tracking ABBOTT LABORATORIES dividends might help you take more informed decisions.
ABBOTT LABORATORIES dividend yield was 1.98% in 2024, and payout ratio reached 29.33%. The year before the numbers were 1.89% and 63.81% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 114 K employees. See our rating of the largest employees — is ABBOTT LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABORATORIES EBITDA is 9.75 B EUR, and current EBITDA margin is 24.00%. See more stats in ABBOTT LABORATORIES financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBOTT LABORATORIES technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBOTT LABORATORIES stock shows the buy signal. See more of ABBOTT LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.